This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Institute of Cancer Research: Royal Cancer Hospital. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovations of Andrew Kalusa
Introduction
Andrew Kalusa is an accomplished inventor based in Sutton, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds. His work is particularly focused on fused heterocyclic compounds, which have promising applications in pharmaceuticals.
Latest Patents
Andrew Kalusa holds a patent for "Fused heterocyclic compounds and their use." This invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates, and solvates thereof for use in the treatment of cancer. His patent represents a crucial step forward in the search for effective cancer therapies, showcasing his commitment to improving patient outcomes.
Career Highlights
Kalusa is affiliated with The Institute of Cancer Research, Royal Cancer Hospital, where he conducts his research. His work at this prestigious institution has allowed him to collaborate with leading experts in the field and contribute to groundbreaking advancements in cancer treatment.
Collaborations
Throughout his career, Andrew has worked alongside notable colleagues, including Keith Jones and Matthew D Cheeseman. These collaborations have enriched his research and expanded the impact of his innovations in the medical community.
Conclusion
Andrew Kalusa's contributions to cancer research through his patented innovations highlight his dedication to improving healthcare. His work exemplifies the vital role of inventors in advancing medical science and enhancing treatment options for patients.